Join
Live feed
·
INSIDERFilingvia Quantisnow
Lyra Therapeutics Inc. logo

Chief Financial Officer Cavalier Jason sold $6,094 worth of shares (684 units at $8.91), decreasing direct ownership by 0.13% to 519,316 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LYRA· Lyra Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LYRA (Lyra Therapeutics Inc.) and more on Quantisnow.